Prothena Corporation plc - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated May 21, 2014, details the results of Prothena Corporation plc's 2014 Annual General Meeting of Shareholders. The company is incorporated in Ireland with principal executive offices in South San Francisco, California.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters and shareholder voting results.
Material Changes and Voting Results
Shareholders voted on three proposals at the Annual General Meeting:
- Proposal 1: Election of Directors. All three nominees were re-elected to the Board of Directors for a term ending in 2017.
- Dr. Dale B. Schenk: 16,519,553 For; 151,080 Against.
- Dr. Dennis J. Selkoe: 16,549,383 For; 121,893 Against.
- Richard T. Collier: 15,603,647 For; 1,067,027 Against.
- Proposal 2: Ratification of Auditor. Shareholders ratified the selection of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2014.
- Vote Count: 19,103,242 For; 109,744 Against.
- Proposal 3: Long Term Incentive Plan. Shareholders approved the Prothena Corporation plc Amended and Restated 2012 Long Term Incentive Plan.
- Vote Count: 12,752,174 For; 3,901,009 Against.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, management outlook, specific risks, contingencies, or unusual items. The document serves solely to report the outcome of the shareholder vote.
Key Facts for Investor Verification
- Confirmation that KPMG LLP is the appointed auditor for the fiscal year ending December 31, 2014.
- Verification of the approved Amended and Restated 2012 Long Term Incentive Plan terms.
- Confirmation of the Board of Directors composition following the re-election of Dr. Schenk, Dr. Selkoe, and Mr. Collier.